TREA

90715256 - CRISPR THERAPEUTICS

Follow

Information

  • Trademark
  • 90715256
  • Serial Number
    90715256
  • Registration Number
    6724517
  • Filing Date
    May 17, 2021
    3 years ago
  • Registration Date
    May 24, 2022
    2 years ago
  • Transaction Date
    September 22, 2023
    a year ago
  • Status Date
    May 24, 2022
    2 years ago
  • Published for Opposition Date
    February 22, 2022
    2 years ago
  • Location Date
    May 24, 2022
    2 years ago
  • First Use Anywhere Date
    November 01, 2013
    11 years ago
  • First Use In Commerce Date
    November 01, 2013
    11 years ago
  • Status Code
    700
  • Current Location
    PUBLICATION AND ISSUE SECTION
    Employee Name
    BAL, KAMAL SINGH
  • Attorney Name
    Tiffany D. Gehrke
    Law Office Assigned Location Code
    N10
  • Owners
Information
Mark Drawing Code
4000
Mark Identification
CRISPR THERAPEUTICS
Case File Statements
  • GS0411: Education services, namely, providing on-line non-downloadable articles and newsletters in the field of pharmaceuticals, genetics, genome editing, gene editing, genome engineering, gene modulation, transcriptional regulation, transcriptional modulation, genetic diseases, gene therapy and cell therapy
  • GS0421: Scientific research and development, namely, gene editing for researching and developing human cells and pharmaceuticals; research and development of therapeutics pharmaceuticals using gene editing; pharmaceutical, medical, scientific, and biopharmaceutical research and development; medical laboratory services; scientific laboratory services; custom cell-line engineering services; medical and scientific research in the fields of pharmaceuticals, genetics, genome editing, gene editing, genome engineering, gene modulation, transcriptional regulation, transcriptional modulation, genetic diseases, gene therapy and cell therapy; providing medical research and scientific research information in the fields of pharmaceuticals, genetics, genome editing, gene editing, genome engineering, gene modulation, transcriptional regulation, transcriptional modulation, genetic diseases, gene therapy and cell therapy; scientific research and development services relating to targeting genetic therapies to individuals
Case File Event Statements
  • 5/24/2022 - 2 years ago
    13 - NOTICE OF REGISTRATION CONFIRMATION EMAILED Type: NRCC
  • 5/24/2022 - 2 years ago
    12 - REGISTERED-PRINCIPAL REGISTER Type: R.PR
  • 2/22/2022 - 2 years ago
    11 - OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED Type: NPUB
  • 2/22/2022 - 2 years ago
    10 - PUBLISHED FOR OPPOSITION Type: PUBO
  • 2/2/2022 - 2 years ago
    9 - NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED Type: NONP
  • 1/19/2022 - 2 years ago
    8 - APPROVED FOR PUB - PRINCIPAL REGISTER Type: CNSA
  • 1/19/2022 - 2 years ago
    7 - EXAMINER'S AMENDMENT ENTERED Type: XAEC
  • 1/19/2022 - 2 years ago
    6 - NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED Type: GNEN
  • 1/19/2022 - 2 years ago
    5 - EXAMINERS AMENDMENT E-MAILED Type: GNEA
  • 1/19/2022 - 2 years ago
    4 - EXAMINERS AMENDMENT -WRITTEN Type: CNEA
  • 1/11/2022 - 2 years ago
    3 - ASSIGNED TO EXAMINER Type: DOCK
  • 8/14/2021 - 3 years ago
    2 - NEW APPLICATION OFFICE SUPPLIED DATA ENTERED Type: NWOS
  • 5/20/2021 - 3 years ago
    1 - NEW APPLICATION ENTERED Type: NWAP